Chairman and CEO
As venture capitalist: Founder and CEO of Quantica SGR, Founder and Investment Manager of Axòn Capital, Venture Consultant at Sofinnova Partners and Venture Partner at AurorA Science; Investor and Board Director at EOS – Ethical Oncology Science. Member of the Assobiotec Steering Committee; Member of the ItaliaStartup Board; Board Member at Altheia Science; Member of the Life Sciences Technical Group at Confindustria
McKinsey & Company emeritus director and former board member at Luxottica (NYSE:LUX), COFIDE (IT:COF), Teva (NYSE: TEVA), and Admiral (LSE: ADM). Chairman of the INSEAD’s advisory group in Italy.
35 years at global top positions in big pharmaceuticals at all levels; managed staff up to 7,000 employees with turnover over 7B€; former Head of Pharma EU at Novartis, previously Head of Oncology at Novartis EU (drugs: Cosentyx, Entresto, Lucentis, Gilenya, Xolair, Ultibro, Seebri, Galvus, Exforge and others)
Deputy Scientific Director, OSR - San Raffaele Hospital, Milano, Italy; Adjunct Member, Department of Immunology & Microbial Sciences, The Scripps Research Institute (TSRI), La Jolla, California, USA; Full Professor of General Pathology, UniSR, Medical School, Milano; Head, Immunopathology Unit, OSR, Milano, Italy.
Deputy COO Research OSR - San Raffaele Hospital, Milano, Italy; former COO Research IEO – European Institute of Oncology and Monzino Cardiologic Center, Milano; former Board Member and CFO at TT-Factor, Ifom-IEO Tech Transfer Office, and in several biotech start-ups and spin-offs.